{"id":"https://openalex.org/keywords/nialamide","display_name":"nialamide","description":"A monoamine oxidase inhibitor drug investigated for pharmacological effects and historically used as a psychotherapeutic agent.","display_name_alternatives":["Niamid","Nuredal","nialamid","N-benzyl-3-(2-isonicotinoylhydrazino)propanamide","N-benzyl-beta-(isonicotinylhydrazino)propionamide","1-[2-(benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine","isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide"],"ids":{"openalex":"https://openalex.org/keywords/nialamide","wikidata":"https://www.wikidata.org/wiki/Q2359711"},"primary_topic":null,"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.1769,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.1018,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0768,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"works_count":971,"cited_by_count":23619,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/nialamide","updated_date":"2026-11-17T04:05:58","created_date":"2022-04-12T19:38:12"}
